Loerop James
Insider CIK 1781549 · ACRS Chief Business Officer · ANIK EVP Business Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-03 | 2026-02-05 | 20,875 | — | $0 | 62,625 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-02-03 | 2026-02-05 | 5,937 | $3.47 | $20.6K | 192,260 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-03 | 2026-02-05 | 20,875 | — | $0 | 198,197 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-06 | 97,700 | — | $0 | 97,700 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-06 | 341,900 | — | $0 | 341,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-01 | 2026-02-05 | 14,750 | — | $0 | 29,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-01 | 2026-02-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-01 | 2026-02-05 | 11,250 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-01 | 2026-02-05 | 14,750 | — | $0 | 188,008 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-01 | 2026-02-05 | 11,250 | — | $0 | 165,758 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-02-01 | 2026-02-05 | 10,686 | $3.51 | $37.5K | 177,322 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-01 | 2026-02-05 | 7,500 | — | $0 | 173,258 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-01-02 | 2026-01-05 | 18,150 | — | $0 | 18,700 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-01-02 | 2026-01-05 | 18,150 | — | $0 | 161,212 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-01-02 | 2026-01-05 | 6,171 | $2.88 | $17.8K | 155,041 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-05 | 73,750 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-12-31 | 2026-01-05 | 73,750 | — | $0 | 177,056 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 33,994 | $3.01 | $102.3K | 143,062 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 83,500 | — | $0 | 83,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 292,300 | — | $0 | 292,300 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-02-01 | 2026-02-03 | 15,980 | $2.48 | $39.6K | 102,773 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-02-01 | 2026-02-03 | 15,980 | $2.48 | $39.6K | 102,773 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 14,750 | — | $0 | 44,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 7,500 | — | $0 | 15,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-02-01 | 2025-02-04 | 15,447 | $2.48 | $38.3K | 103,306 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 11,250 | — | $0 | 96,503 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 7,500 | — | $0 | 104,003 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 14,750 | — | $0 | 118,753 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-01-02 | 2025-01-03 | 18,150 | — | $0 | 36,850 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-01-02 | 2025-01-03 | 18,150 | — | $0 | 93,828 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-01-02 | 2025-01-03 | 8,575 | $2.48 | $21.3K | 85,253 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-12-31 | 2025-01-03 | 73,750 | — | $0 | 73,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-12-31 | 2025-01-03 | 32,089 | $2.48 | $79.6K | 75,678 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-12-31 | 2025-01-03 | 73,750 | — | $0 | 107,767 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 59,000 | — | $0 | 59,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-02-01 | 2024-02-05 | 11,250 | — | $0 | 22,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 147,500 | — | $0 | 147,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 206,500 | — | $0 | 206,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-02-01 | 2024-02-05 | 7,500 | — | $0 | 22,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-02-01 | 2024-02-05 | 3,853 | $1.20 | $4.6K | 29,085 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-02-01 | 2024-02-05 | 11,250 | — | $0 | 32,938 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-02-01 | 2024-02-05 | 2,568 | $1.20 | $3.1K | 34,017 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-02-01 | 2024-02-05 | 7,500 | — | $0 | 36,585 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2023-08-28 | 2023-08-28 | 14,705 | $6.80 | $100.0K | 21,688 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-08 | 2023-02-10 | 4,267 | $13.89 | $59.3K | 6,983 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 105,000 | — | $0 | 105,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-02-01 | 2023-02-03 | 11,250 | — | $0 | 33,750 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-02-01 | 2023-02-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-01 | 155,000 | — | $0 | 155,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2021-07-08 | 2021-07-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | F Tax w/h | 2021-07-08 | 2021-07-12 | 731 | $43.24 | $31.6K | 5,592 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2021-07-08 | 2021-07-12 | 3,000 | — | $0 | 6,323 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2021-03-09 | 2021-03-11 | 16,802 | — | $0 | 16,802 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2021-03-09 | 2021-03-11 | 6,705 | — | $0 | 6,705 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise deriv | 2021-02-25 | 2021-03-01 | 1,567 | — | $0 | 3,133 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | M Exercise | 2021-02-25 | 2021-03-01 | 1,567 | — | $0 | 3,323 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | S Sale | 2020-07-09 | 2020-07-10 | 1,244 | $35.15 | $43.7K | 1,756 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award | 2020-07-08 | 2020-07-10 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2020-02-25 | 2020-02-27 | 4,700 | — | $0 | 4,700 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2019-07-08 | 2019-07-09 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ANIK Anika Therapeutics, Inc. | A Award deriv | 2019-07-08 | 2019-07-09 | 27,000 | — | $0 | 27,000 | SEC↗ |